DEF 14C

DEFINITIVE INFORMATION STATEMENT SCHEDULE 14C

Company: Theriva Biologics, Inc.
Filed: September 20, 2005
Period of Report: September 20, 2005
Accession Number: 0001295345-05-000033

View Document ↗ View on SEC.gov ↗